Press release: Paper: Website: #GLP1 #BariatricSurgery #MetabolicDisease #MedTech To view or add a comment, sign in New data released last week at the American Society For Metabolic And Bariatric Surgery (ASMBS) Annual Meeting found that bariatric surgery significantly outperformed GLP-1 medications for long-term weight loss and remission of obesity-related disease
Important safety considerations include a boxed warning for medullary thyroid carcinoma risk and contraindication in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
A lantus insulin pen can help standardize technique and dosing increments, which may reduce variability
Safety As expected, nausea, diarrhea, constipation, and vomiting were the most common serious adverse events reported
BW, blood chemistries and metabolic profiling were measured weekly
In transcripts obtained by the BBC, Farah denies having been given the injection in the initial 2015 interview with Usada